Literature DB >> 1727377

Morphological reversion of sis-transformed NIH3T3 cells by trichostatin A.

K Sugita1, K Koizumi, H Yoshida.   

Abstract

Trichostatin A (TSA) induced the normal and flat phenotype of sis-transformed NIH3T3 cells at quite a low concentration of 1 ng/ml. Although morphological changes were found in other oncogene-transformed cells, they were not the same as those seen for the sis-transformed cells. Almost complete reversion into the flat phenotype was seen at 6 h after administration of the compound, suggesting that the morphological change was caused not merely by selection of TSA-resistant cells of the flat phenotype. The effect of TSA was reversible when the cell culture was incubated after its removal. Synthesis of sis-mRNA did not decrease with the treatment of TSA at a concentration sufficient to reverse the transformed morphology. Cycloheximide abolished the activity of TSA, showing that TSA required new protein synthesis to express its activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1727377

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Identification of mouse histone deacetylase 1 as a growth factor-inducible gene.

Authors:  S Bartl; J Taplick; G Lagger; H Khier; K Kuchler; C Seiser
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Growth inhibition by the mammalian SWI-SNF subunit Brm is regulated by acetylation.

Authors:  Brigitte Bourachot; Moshe Yaniv; Christian Muchardt
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

Review 3.  Histone modifications: Targeting head and neck cancer stem cells.

Authors:  John M Le; Cristiane H Squarize; Rogerio M Castilho
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

4.  Role of histone deacetylation in developmentally programmed DNA rearrangements in Tetrahymena thermophila.

Authors:  Sandra Duharcourt; Meng-Chao Yao
Journal:  Eukaryot Cell       Date:  2002-04

Review 5.  A chemical probe toolbox for dissecting the cancer epigenome.

Authors:  Jake Shortt; Christopher J Ott; Ricky W Johnstone; James E Bradner
Journal:  Nat Rev Cancer       Date:  2017-02-23       Impact factor: 60.716

6.  Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase.

Authors:  H J Kwon; T Owa; C A Hassig; J Shimada; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

7.  A Phase II Clinical Trial of Oral Valproic Acid in Patients with Castration-Resistant Prostate Cancers Using an Intensive Biomarker Sampling Strategy.

Authors:  Sunil Sharma; James Symanowski; Bryan Wong; Pamela Dino; Phillip Manno; Nicholas Vogelzang
Journal:  Transl Oncol       Date:  2008-09       Impact factor: 4.243

8.  Complementation of two related tumour cell classes during experimental metastasis tagged with different histochemical marker genes.

Authors:  W C Lin; K L O'Connor; L A Culp
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

9.  Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer.

Authors:  Fernanda S Giudice; Decio S Pinto; Jacques E Nör; Cristiane H Squarize; Rogerio M Castilho
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

10.  Requirement for RAR-mediated gene repression in skeletal progenitor differentiation.

Authors:  Andrea D Weston; Roshantha A S Chandraratna; Joseph Torchia; T Michael Underhill
Journal:  J Cell Biol       Date:  2002-07-08       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.